Is Pacira Biosciences, Inc. technically bullish or bearish?

As of 3 October 2025, the technical trend for Pacira Biosciences, Inc. has changed from bullish to mildly bullish. The current stance is mildly bullish, supported by the monthly MACD and KST indicators, both showing mildly bullish signals. However, the weekly MACD and Dow Theory indicate a mildly bearish stance, which tempers the overall bullish outlook. The daily moving averages are mildly bullish, while Bollinger Bands on the weekly timeframe are bearish, further contributing to mixed signals.
In terms of performance, Pacira has outperformed the S&P 500 on a year-to-date basis with a return of 26.70% compared to the S&P's 14.18%, and it has also significantly outperformed over the past year with a return of 44.54% versus 17.82%. However, the longer-term returns over 3 and 5 years are notably negative compared to the S&P 500.